- Report
- April 2025
- 200 Pages
Global
From €4091EUR$4,490USD£3,552GBP
- Report
- January 2025
- 200 Pages
Global
From €4091EUR$4,490USD£3,552GBP
- Report
- July 2024
- 180 Pages
Global
From €4100EUR$4,500USD£3,560GBP
- Report
- February 2025
- 180 Pages
Global
From €4100EUR$4,500USD£3,560GBP
- Report
- September 2024
- 289 Pages
Global
From €3280EUR$3,600USD£2,848GBP
- Report
- October 2024
- 164 Pages
Global
From €3644EUR$4,000USD£3,165GBP
- Report
- October 2024
- 131 Pages
Asia Pacific
From €3644EUR$4,000USD£3,165GBP
- Report
- June 2023
- 142 Pages
Global
From €4556EUR$5,000USD£3,956GBP
- Report
- April 2023
- 600 Pages
Global
From €5467EUR$6,000USD£4,747GBP
- Report
- January 2023
- 195 Pages
Latin America
From €4556EUR$5,000USD£3,956GBP
- Report
- January 2023
- 178 Pages
Global
From €4556EUR$5,000USD£3,956GBP
- Report
- October 2022
- 348 Pages
Singapore, Indonesia, ... Singapore, Indonesia, Malaysia
From €4556EUR$5,000USD£3,956GBP
- Report
- October 2022
- 220 Pages
United States
From €4556EUR$5,000USD£3,956GBP
- Report
- June 2022
- 55 Pages
India
From €4556EUR$5,000USD£3,956GBP
- Report
- March 2022
- 312 Pages
Global
From €6378EUR$7,000USD£5,538GBP
- Report
- November 2021
- 39 Pages
Global
From €2733EUR$3,000USD£2,373GBP
- Report
- September 2021
- 144 Pages
China
From €3644EUR$4,000USD£3,165GBP
- Report
- June 2021
- 197 Pages
Latin America
From €3644EUR$4,000USD£3,165GBP
- Report
- March 2021
- 54 Pages
Global
From €2733EUR$3,000USD£2,373GBP
- Report
- March 2024
- 55 Pages
Global
From €4556EUR$5,000USD£3,956GBP

The HbA1C Testing market within the Biotechnology industry is a rapidly growing sector. It is used to measure the average amount of glucose in the blood over a period of two to three months. This test is used to diagnose and monitor diabetes, as well as to assess the effectiveness of diabetes treatments. It is also used to detect pre-diabetes and to monitor the risk of developing diabetes.
The HbA1C Testing market is driven by the increasing prevalence of diabetes, the growing awareness of the importance of early diagnosis and treatment, and the availability of advanced testing technologies. The market is also supported by the increasing demand for point-of-care testing and the development of new products.
Some of the major companies in the HbA1C Testing market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Alere, and Bio-Rad Laboratories. Show Less Read more